{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:42:14Z","timestamp":1779918134947,"version":"3.53.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-68\/2022-14\/200026"],"award-info":[{"award-number":["451-03-68\/2022-14\/200026"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-68\/2022-14\/200026"],"award-info":[{"award-number":["451-03-68\/2022-14\/200026"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-68\/2022-14\/200026"],"award-info":[{"award-number":["451-03-68\/2022-14\/200026"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-68\/2022-14\/200168"],"award-info":[{"award-number":["451-03-68\/2022-14\/200168"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s12010-022-03922-8","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T12:03:05Z","timestamp":1651665785000},"page":"3749-3764","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Therapeutic Potential of 2-{[4-(2-methoxyphenyl)piperazin-1-yl]alkyl}-1H-benzo[d]imidazoles as Ligands for Alpha1-Adrenergic Receptor - Comparative In Silico and In Vitro Study"],"prefix":"10.1007","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-1193","authenticated-orcid":false,"given":"Jelena Z.","family":"Penji\u0161evi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8972-1132","authenticated-orcid":false,"given":"Vladimir B.","family":"\u0160ukalovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0753-6516","authenticated-orcid":false,"given":"Deana B.","family":"Andri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1599-6210","authenticated-orcid":false,"given":"Relja","family":"Suru\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0777-3076","authenticated-orcid":false,"given":"Sladjana V.","family":"Kosti\u0107-Raja\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"3922_CR1","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/S0024-3205(02)02012-X","volume":"71","author":"A Tanoue","year":"2002","unstructured":"Tanoue, A., Koshimizu, T. A., & Tsujimoto, G. (2002). Transgenic studies of \u03b11-adrenergic receptor subtype function. Life Sciences, 71, 2207\u20132215. https:\/\/doi.org\/10.1016\/S0024-3205(02)02012-X","journal-title":"Life Sciences"},{"key":"3922_CR2","first-page":"267","volume":"47","author":"JP Hieble","year":"1995","unstructured":"Hieble, J. P., Bylund, D. B., Clarke, C. E., Eikenburg, D. C., Langer, S. Z., Lefkowitz, R. J., & Ruffolo, R. R., Jr. (1995). International union of pharmacology. X. Recommendatin for nomenclature of \u03b11-adenoreceptors: Consensus update. Pharmacological Reviews, 47, 267\u2013270","journal-title":"Pharmacological Reviews"},{"key":"3922_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/syn.20709","volume":"64","author":"K Buck","year":"2010","unstructured":"Buck, K., & Ferger, B. (2010). The selective \u03b11 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson\u2019s disease. Synapse (New York, N. Y.), 64, 117\u2013126. https:\/\/doi.org\/10.1002\/syn.20709","journal-title":"Synapse (New York, N. Y.)"},{"key":"3922_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnins.2015.00220","volume":"9","author":"M Gannon","year":"2015","unstructured":"Gannon, M., Che, P., Chen, Y., Jiao, K., Roberson, E. D., & Wang, Q. (2015). Noradrenergic dysfunction in Alzheimer\u2019s disease. Frontiers in Neuroscience, 9, 220\u2013231. https:\/\/doi.org\/10.3389\/fnins.2015.00220","journal-title":"Frontiers in Neuroscience"},{"key":"3922_CR5","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.1016\/j.bmc.2008.04.058","volume":"16","author":"J Handzlik","year":"2008","unstructured":"Handzlik, J., Maciag, D., Kubacka, M., Mogilski, S., Filipek, B., Stadnicka, K., & Kie\u0107-Kononowicz, K. (2008). Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin. Bioorganic & Medicinal Chemistry, 16, 5982\u20135998. https:\/\/doi.org\/10.1016\/j.bmc.2008.04.058","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"3922_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-0042-107794","volume":"50","author":"S Roepke","year":"2017","unstructured":"Roepke, S., Danker-Hopfe, H., Repantis, D., Behnia, B., Bernard, F., Hansen, M. L., & Otte, C. (2017). Doxazosin, an \u03b11-adrenergic-receptor antagonist, for nightmares in patients with posttraumatic stress disorder and\/or borderline personality disorder: A chart review. Pharmacopsychiatry, 50, 26\u201331. https:\/\/doi.org\/10.1055\/s-0042-107794","journal-title":"Pharmacopsychiatry"},{"key":"3922_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuropharm.2017.04.005","volume":"119","author":"KT Schmidt","year":"2017","unstructured":"Schmidt, K. T., Schroeder, J. P., Foster, S. L., Squires, K., Smith, B. M., Pitts, E. G., & Weinshenker, D. (2017). Norepinephrine regulates cocaine-primed reinstatement via \u03b11-adrenergic receptors in the medial prefrontal cortex. Neuropharmacology, 119, 134\u2013140. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.005","journal-title":"Neuropharmacology"},{"key":"3922_CR8","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/acer.12703","volume":"39","author":"TL Simpson","year":"2015","unstructured":"Simpson, T. L., Malte, C. A., Dietel, B., Tell, D., Pocock, I., Lyons, R., & Saxon, A. J. (2015). A pilot trial of Prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder. Alcoholism, Clinical and Experimental Research, 39, 808\u2013817. https:\/\/doi.org\/10.1111\/acer.12703","journal-title":"Alcoholism, Clinical and Experimental Research"},{"key":"3922_CR9","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ejmech.2016.06.052","volume":"122","author":"RO Silva","year":"2016","unstructured":"Silva, R. O., de Oliveira, A. S., Lemes, N., de Camargo Nascente, L. F., Coelho do Nascimento Nogueira, L., Silveira, P., & Romeiro, L. A. S. (2016). Synthesis and structure\u2013activity relationships of novel arylpiperazines as potent antagonists of \u03b11-adrenoceptor. European Journal of Medicinal Chemistry, 122, 601\u2013610. https:\/\/doi.org\/10.1016\/j.ejmech.2016.06.052","journal-title":"European Journal of Medicinal Chemistry"},{"key":"3922_CR10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jacc.2019.12.033","volume":"75","author":"DA Stakos","year":"2020","unstructured":"Stakos, D. A., Stamatelopoulos, K., Bampatsias, D., Sachse, M., Zormpas, E., Vlachogiannis, N. I., & Stellos, K. (2020). The Alzheimer\u2019s disease amyloid-beta hypothesis in cardiovascular aging and disease: JACC Focus Seminar. Journal of the American College of Cardiology, 75, 952\u2013967. https:\/\/doi.org\/10.1016\/j.jacc.2019.12.033","journal-title":"Journal of the American College of Cardiology"},{"key":"3922_CR11","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.neurobiolaging.2012.09.010","volume":"34","author":"L Katsouri","year":"2013","unstructured":"Katsouri, L., Vizcaychipi, M. P., McArthur, S., Harrison, I., Su\u00e1rez-Calvet, M., Lleo, A., & Sastre, M. (2013). Prazosin, an \u03b11-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer\u2019s disease. Neurobiology of Aging, 34, 1105\u20131115. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.09.010","journal-title":"Neurobiology of Aging"},{"key":"3922_CR12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/JGP.0b013e3181ab8c61","volume":"17","author":"LY Wang","year":"2009","unstructured":"Wang, L. Y., Shofer, J. B., Rohde, K., Hart, K. L., Hoff, D. J., McFall, Y. H., & Peskind, E. R. (2009). Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. The American Journal of Geriatric Psychiatry, 17, 744\u2013751. https:\/\/doi.org\/10.1097\/JGP.0b013e3181ab8c61","journal-title":"The American Journal of Geriatric Psychiatry"},{"key":"3922_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnsyn.2019.00027","volume":"11","author":"K Dyer-Reaves","year":"2019","unstructured":"Dyer-Reaves, K., Goodman, A. M., Nelson, A. R., & McMahon, L. L. (2019). Alpha1-adrenergic receptor mediated long-term depression at CA3-CA1 synapses can be induced via accumulation of endogenous norepinephrine and is preserved following noradrenergic denervation. Frontiers in Synaptic Neuroscience, 11, 27. https:\/\/doi.org\/10.3389\/fnsyn.2019.00027","journal-title":"Frontiers in Synaptic Neuroscience"},{"key":"3922_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0960-894X(01)00772-7","volume":"12","author":"L Betti","year":"2002","unstructured":"Betti, L., Botta, M., Corelli, F., Floridi, M., Fossa, P., Giannaccini, G., & Corsano, S. (2002). \u03b11-Adrenoceptor antagonists. Rational design, synthesis and biological evaluation of new trazodone-like compounds. Bioorganic & Medicinal Chemistry Letters, 12, 437\u2013440. https:\/\/doi.org\/10.1016\/S0960-894X(01)00772-7","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"3922_CR15","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1016\/j.bmcl.2005.05.003","volume":"15","author":"MY Li","year":"2005","unstructured":"Li, M. Y., Fang, H., & Xia, L. (2005). Pharmacophore-based design, synthesis, biological evaluation, and 3D-QSAR studies of aryl-piperazines as \u03b11-adrenoceptor antagonists. Bioorganic & Medicinal Chemistry Letters, 15, 3216\u20133219. https:\/\/doi.org\/10.1016\/j.bmcl.2005.05.003","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"3922_CR16","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/00498250210163298","volume":"32","author":"Z Yan","year":"2002","unstructured":"Yan, Z., Caldwell, G. W., Wu, W. N., McKown, L. A., Rafferty, B., Jones, W., & Masucci, J. A. (2002). In vitro identification of metabolic pathways and cytochrome P450 enzymes involved in the metabolism of etoperidone. Xenobiotica, 32, 949\u2013962. https:\/\/doi.org\/10.1080\/00498250210163298","journal-title":"Xenobiotica"},{"key":"3922_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.bmcl.2018.01.068","volume":"28","author":"JJ Huang","year":"2018","unstructured":"Huang, J. J., Zhang, Z. H., He, F., Liu, X. W., Xu, X. J., Dai, L. J., & Yuan, M. (2018). Novel naftopidil derivatives containing methyl phenylacetate and their blocking effects on \u03b11D\/1A-adrenore-ceptor subtypes. Bioorg. Med. Chem. Lett, 28, 547\u2013551. https:\/\/doi.org\/10.1016\/j.bmcl.2018.01.068","journal-title":"Med. Chem. Lett"},{"key":"3922_CR18","first-page":"180","volume":"272","author":"K Zech","year":"1984","unstructured":"Zech, K., Eltze, M., Kilian, U., Sanders, K. H., & Kolassa, N. (1984). Biotransformation of urapidil: Metabolites in serum and urine and their biological activity in vitro and in vivo. Archives Internationales de Pharmacodynamie et de Thrapie, 272, 180\u2013196","journal-title":"Archives Internationales de Pharmacodynamie et de Thrapie"},{"key":"3922_CR19","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2298\/JSC181029104P","volume":"84","author":"JZ Penji\u0161evi\u0107","year":"2019","unstructured":"Penji\u0161evi\u0107, J. Z., Andri\u0107, D. B., \u0160ukalovi\u0107, V. B., Rogli\u0107, G. M., \u0160o\u0161ki\u0107, V., & Kosti\u0107-Raja\u010di\u0107, S. V. (2019). Synthesis of novel 2-(piperazino-1-yl-alkyl)-1H-benzimidazole derivates and assessment of their interactions with the D2 dopamine receptor. The Journal of the Serbian Chemical Society, 84, 925\u2013934. https:\/\/doi.org\/10.2298\/JSC181029104P","journal-title":"The Journal of the Serbian Chemical Society"},{"key":"3922_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/ph14070663","volume":"14","author":"R Veerasamy","year":"2021","unstructured":"Veerasamy, R., Roy, A., Karunakaran, R., & Rajak, H. (2021). Structure-activity relationship analysis of benzimidazoles as emerging anti-inflammatory agents: An overview. Pharmaceuticals, 14, 663. https:\/\/doi.org\/10.3390\/ph14070663","journal-title":"Pharmaceuticals"},{"key":"3922_CR21","doi-asserted-by":"publisher","first-page":"112529","DOI":"10.1016\/j.ejmech.2020.112529","volume":"203","author":"S Sudo\u0142","year":"2020","unstructured":"Sudo\u0142, S., Kucwaj-Brysz, K., Kurczab, R., Wilczy\u0144ska, N., Jastrz\u0119bska-Wi\u0119sek, M., Sata\u0142a, G., & Handzlik, J. (2020). Chlorine substituents and linker topology as factors of 5-HT6R activity for novel highly active 1,3,5-triazine derivatives with procognitive properties in vivo. European Journal of Medicinal Chemistry, 203, 112529. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112529","journal-title":"European Journal of Medicinal Chemistry"},{"key":"3922_CR22","unstructured":"Vogel, H. G., & Vogel, W. H. (Eds.). (2002). In Drug Discovery and Evaluation \u2013 Pharmacological Assays, chapter E: Psychotropic and Neurotropic Activity (2nd ed., pp. 602\u2013607). Springer-Verlag\u00a0"},{"key":"3922_CR23","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1016\/j.bmcl.2004.06.005","volume":"14","author":"M Tomi\u0107","year":"2004","unstructured":"Tomi\u0107, M., Kundakovi\u0107, M., Butorovi\u0107, B., Jana\u0107, B., Andri\u0107, D., Rogli\u0107, G., & Kosti\u0107-Raja\u010di\u0107, S. (2004). Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential. Bioorganic & Medicinal Chemistry Letters, 14, 4263\u20134266. https:\/\/doi.org\/10.1016\/j.bmcl.2004.06.005","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"3922_CR24","unstructured":"GraphPad Prism version 8.0.0 for Windows.\u00a0GraphPad Software. https:\/\/www.graphpad.com"},{"key":"3922_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1747-0285.2005.00327.x","volume":"67","author":"W Sherman","year":"2006","unstructured":"Sherman, W., Beard, H. S., & Farid, R. (2006). Use of an induced fit receptor structure in virtual screening. Chemical Biology & Drug Design, 67, 83\u201384. https:\/\/doi.org\/10.1111\/j.1747-0285.2005.00327.x","journal-title":"Chemical Biology & Drug Design"},{"key":"3922_CR26","unstructured":"Schr\u00f6dinger Release 2018\u20134. (2018). Maestro, Schr\u00f6dinger, LLC, New York, NY. https:\/\/www.schrodinger.com\/citations#Maestro"},{"key":"3922_CR27","doi-asserted-by":"publisher","first-page":"D335","DOI":"10.1093\/nar\/gkaa1080","volume":"49","author":"AJ Kooistra","year":"2021","unstructured":"Kooistra, A. J., Mordalski, S., P\u00e1ndy-Szekeres, G., Esguerra, M., Mamyrbekov, A., Munk, C., & Gloriam, D. E. (2021). GPCRdb in 2021: Integrating GPCR sequence, structure and function. Nucleic Acids Research, 49, D335\u2013D343. https:\/\/doi.org\/10.1093\/nar\/gkaa1080","journal-title":"Nucleic Acids Research"},{"key":"3922_CR28","doi-asserted-by":"publisher","unstructured":"Bowers, K. J., Chow, E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A. \u2026 Shaw, D. E. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. SC \u201806: Proceedings of the 2006 ACM\/IEEE conference on Supercomputing. November, 84-es. https:\/\/doi.org\/10.1145\/1188455.1188544","DOI":"10.1145\/1188455.1188544"},{"key":"3922_CR29","unstructured":"Orientations of Proteins in\u00a0Membranes (OPM) database. Available from: http:\/\/opm.phar.umich.edu\/. Accessed 15 June 15 2021\u00a0"},{"key":"3922_CR30","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Scientific Reports"},{"key":"3922_CR31","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1021\/acs.jcim.9b00376","volume":"59","author":"M \u0160\u00edcho","year":"2019","unstructured":"\u0160\u00edcho, M., Stork, C., Mazzolari, A., de Bruyn Kops, C., Pedretti, A., Testa, B., & Kirchmair, J. (2019). FAME 3: Predicting the sites of metabolism in synthetic compounds and natural products for phase 1 and phase 2 metabolic enzymes. Journal of Chemical Information and Modeling, 59, 3400\u20133412. https:\/\/doi.org\/10.1021\/acs.jcim.9b00376","journal-title":"Journal of Chemical Information and Modeling"},{"key":"3922_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fchem.2019.00402","volume":"7","author":"C de Bruyn Kops","year":"2019","unstructured":"de Bruyn Kops, C., Stork, C., \u0160\u00edcho, M., Kochev, N., Svozil, D., Jeliazkova, N., & Kirchmair, J. (2019). GLORY: Generator of the structures of likely cytochrome P450 metabolites based on predicted sites of metabolism. Frontiers in Chemistry, 7, 402. https:\/\/doi.org\/10.3389\/fchem.2019.00402","journal-title":"Frontiers in Chemistry"},{"key":"3922_CR33","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s40263-012-0010-5","volume":"26","author":"A Fagiolini","year":"2012","unstructured":"Fagiolini, A., Comandini, A., Dell\u2019Osso, M. C., & Kasper, S. (2012). Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs, 26, 1033\u20131049. https:\/\/doi.org\/10.1007\/s40263-012-0010-5","journal-title":"CNS Drugs"},{"key":"3922_CR34","first-page":"7","volume":"57","author":"H Sakai","year":"2011","unstructured":"Sakai, H., Igawa, T., Onita, T., Furukawa, M., Hakariya, T., Hayashi, M., & Kanetake, H. (2011). Efficacy of naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia: prospective randomized controlled study to compare differences in efficacy between morning and evening medication. Hinyokika Kiyo, 57, 7\u201313","journal-title":"Hinyokika Kiyo"},{"key":"3922_CR35","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/j.1476-5381.1991.tb12290.x","volume":"102","author":"AG Ramage","year":"1991","unstructured":"Ramage, A. G. (1991). The mechanism of the sympathoinhibitory action of urapidil: role of 5-HT1A receptors. British Journal of Pharmacology, 102, 998\u20131002. https:\/\/doi.org\/10.1111\/j.1476-5381.1991.tb12290.x","journal-title":"British Journal of Pharmacology"},{"key":"3922_CR36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2174\/1381612822666151125000550","volume":"22","author":"MH Baig","year":"2016","unstructured":"Baig, M. H., Ahmad, K., Roy, S., Ashraf, J. M., Adil, M., Siddiqui, M. H., & Choi, I. (2016). Computer aided drug design: Success and limitations. Current Pharmaceutical Design, 22, 572\u2013581. https:\/\/doi.org\/10.2174\/1381612822666151125000550","journal-title":"Current Pharmaceutical Design"},{"key":"3922_CR37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.2174\/138920007781368908","volume":"8","author":"S Caccia","year":"2007","unstructured":"Caccia, S. (2007). N-Dealkylation of arylpiperazine derivatives: Disposition and metabolism of the 1-aryl-piperazines formed. Current Drug Metabolism, 8, 612\u2013622. https:\/\/doi.org\/10.2174\/138920007781368908","journal-title":"Current Drug Metabolism"},{"key":"3922_CR38","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1517\/17460441.2012.714363","volume":"7","author":"JA Arnott","year":"2012","unstructured":"Arnott, J. A., & Planey, S. L. (2012). The influence of lipophilicity in drug discovery and design. Expert Opinion on Drug Discovery, 7, 863\u2013875. https:\/\/doi.org\/10.1517\/17460441.2012.714363","journal-title":"Expert Opinion on Drug Discovery"},{"key":"3922_CR39","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45, 2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"Journal of Medicinal Chemistry"},{"key":"3922_CR40","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1021\/ci300487z","volume":"53","author":"J Kirchmair","year":"2013","unstructured":"Kirchmair, J., Howlett, A., Peironcely, J. E., Murrell, D. S., Williamson, M. J., Adams, S. E., & Glen, R. C. (2013). How do metabolites differ from their parent molecules and how are they excreted? Journal of Chemical Information and Modeling, 53, 354\u2013367. https:\/\/doi.org\/10.1021\/ci300487z","journal-title":"Journal of Chemical Information and Modeling"},{"key":"3922_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/minf.201400031","volume":"33","author":"JD Tyzack","year":"2014","unstructured":"Tyzack, J. D., & Glen, R. C. (2014). Investigating and predicting how biology changes molecules and their properties. Molecular Informatics, 33, 443\u2013445. https:\/\/doi.org\/10.1002\/minf.201400031","journal-title":"Molecular Informatics"},{"key":"3922_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.sbi.2017.08.003","volume":"47","author":"JD Tyzack","year":"2017","unstructured":"Tyzack, J. D., Furnham, N., Sillitoe, I., Orengo, C. M., & Thornton, J. M. (2017). Understanding enzyme function evolution from a computational perspective. Current Opinion in Structural Biology, 47, 131\u2013139. https:\/\/doi.org\/10.1016\/j.sbi.2017.08.003","journal-title":"Current Opinion in Structural Biology"},{"key":"3922_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/cbdd.13445","volume":"93","author":"JD Tyzack","year":"2019","unstructured":"Tyzack, J. D., & Kirchmair, J. (2019). Computational methods and tools to predict cytochrome P450 metabolism for drug discovery. Chemical Biology & Drug Design, 93, 377\u2013386. https:\/\/doi.org\/10.1111\/cbdd.13445","journal-title":"Chemical Biology & Drug Design"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-03922-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-022-03922-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-022-03922-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T01:14:02Z","timestamp":1657329242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-022-03922-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["3922"],"URL":"https:\/\/doi.org\/10.1007\/s12010-022-03922-8","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"assertion":[{"value":"14 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental work including animals were approved by the Local Ethical Committee of the University of Belgrade, Institute for Biological Research \u201cSini\u0161a Stankovic\u201d; National Institute of Republic of Serbia (Permit No. 2\u201356\/12), which comply with the European Community Council Directive of November 24th, 1986 (86\/609\/EEC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors read and approved the manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}